Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014

被引：0
|
作者：
Kim, H. [1 ]
Comey, S. [1 ]
机构：
[1] Bristol Myers Squibb, External Affairs, Mulgrave, Australia
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8LBA
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] LATE-BREAKING ABSTRACT: Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014
    Kim, H.
    Comey, S.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S129 - S129
  • [2] Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
    O'Day, Steven
    Ibrahim, Ramy
    De Pril, Veerle
    Maio, Michele
    Sileni, Vanna Chiarion
    Gajewski, Thomas F.
    Pehamberger, Hubert
    Bondarenko, Igor N.
    Queirolo, Paola
    Lundgren, Lotta
    Mikhailov, Sergey
    Roman, Laslo
    Verschraegen, Claire
    Hoos, Axel
    Humphrey, Rachel
    Wolchok, Jedd
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 937 - 938
  • [3] Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab
    Postow, Michael A.
    Chasalow, Scott D.
    Kuk, Deborah
    Panageas, Katherine S.
    Cheng, Michael L.
    Yuan, Jianda
    Wolchok, Jedd D.
    MELANOMA RESEARCH, 2020, 30 (01) : 71 - 75
  • [4] Correlation between baseline parameters and overall survival in patients with advanced melanoma treated with ipilimumab.
    Foppen, Marnix Heimen Geukes
    Jordanova, Ekatarina S.
    Van Thienen, Johannes V.
    Punt, Simone
    Van de Wiel, Bart
    Haanen, John B. A. G.
    Blank, Christian U.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Overall survival in patients with metastatic melanoma treated with concurrent ipilimumab and radiotherapy
    Koller, Kristian Michael
    Mackley, Heath B.
    Wagner, Henry
    Talamo, Giampaolo
    Schell, Todd
    Pameijer, Colette
    Neves, Rogerio Izar
    Anderson, Bryan
    Kokolus, Kathleen M.
    Mallon, Carol
    Drabick, Joseph J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
    Yuan, Jianda
    Zhou, Jun
    Dong, Zhiwan
    Tandon, Sapna
    Kuk, Deborah
    Panageas, Katherine S.
    Wong, Philip
    Wu, Xinqi
    Naidoo, Jarushka
    Page, David B.
    Wolchok, Jedd D.
    Hodi, F. Stephen
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (02) : 127 - 132
  • [7] Ipilimumab Improves Overall Survival in Previously Treated, Advanced Melanoma Patients with Good and Poor Prognostic Factors
    O'Day, Steven J.
    McDermott, David F.
    Urba, Walter J.
    Wolchok, Jedd D.
    Robert, Caroline
    Haanen, John B.
    Dummer, Reinhard
    Messina, Marianne
    Hoos, Axel
    Hodi, F. Stephen
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 905 - 906
  • [8] Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab
    Muto, Yusuke
    Kitano, Shigehisa
    Tsutsumida, Arata
    Namikawa, Kenjiro
    Takahashi, Akira
    Nakamura, Yoshio
    Yamanaka, Takeharu
    Yamamoto, Noboru
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2019, 46 (06): : 498 - 506
  • [9] Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
    Koguchi, Yoshinobu
    Hoen, Helena M.
    Bambina, Shelly A.
    Rynning, Michael D.
    Fuerstenberg, Richard K.
    Curti, Brendan D.
    Urba, Walter J.
    Milburn, Christina
    Bahjat, Frances Rena
    Korman, Alan J.
    Bahjat, Keith S.
    CANCER RESEARCH, 2015, 75 (23) : 5084 - 5092
  • [10] Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
    Reinhard Dummer
    Dirk Schadendorf
    Paolo A Ascierto
    James Larkin
    Celeste Lebbé
    Axel Hauschild
    Journal of Translational Medicine, 12 (Suppl 1)
12345